PTC Therapeutics Inc

PTC Therapeutics Inc


Market Cap$2.52B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
PTC Therapeutics IncPTC Therapeutics Inc-4.30%-2.8-

Target Price by Analysts

3% upsidePTC Therapeutics Target Price DetailsTarget Price

Current Fair Value

12% downside

Overvalued by 12% based on the discounted cash flow analysis.

Share Statistics

Market cap$2.52 Billion
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$-7.67
Outstanding Shares76,696,785
Avg 30 Day Volume1,037,759


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-4.34
Price to Sales2.83
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income0
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About PTC Therapeutics Inc

CEO: Stuart Peltz